These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23796241)

  • 21. Pre-exposure prophylaxis for human immunodeficiency virus: the past, present, and future.
    Castel AD; Magnus M; Greenberg AE
    Infect Dis Clin North Am; 2014 Dec; 28(4):563-83. PubMed ID: 25455314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
    Verguet S; Stalcup M; Walsh JA
    Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From evidence to action: challenges for the Brazilian Unified National Health System in offering pre-exposure prophylaxis (PrEP) for HIV to persons with the greatest vulnerability].
    Zucchi EM; Grangeiro A; Ferraz D; Pinheiro TF; Alencar T; Ferguson L; Estevam DL; Munhoz R;
    Cad Saude Publica; 2018 Jul; 34(7):e00206617. PubMed ID: 30043853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex, PrEP and the moral backlash.
    Serrant L
    Nurs Stand; 2016 Aug; 30(50):27. PubMed ID: 27507374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When the science fails and the ethics works: 'Fail-safe' ethics in the FEM-PrEP study.
    Kingori P
    Anthropol Med; 2015 Dec; 22(3):309-25. PubMed ID: 26484946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical considerations in developing an evidence base for pre-exposure prophylaxis in pregnant women.
    Sullivan KA; Lyerly AD
    Reprod Health; 2017 Dec; 14(Suppl 3):171. PubMed ID: 29297377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perceptions and attitudes about preexposure prophylaxis among seronegative partners and the potential of sexual disinhibition.
    Tripathi A; Whiteside YO; Duffus WA
    South Med J; 2013 Oct; 106(10):558-64. PubMed ID: 24096949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of biomedical interventions in HIV prevention: Pre-exposure Prophylaxis (PrEP)].
    Zioga EAM; Arias-de la Torre J; Patera E; Borjabad B; Macorigh L; Ferrer L
    Semergen; 2020 Apr; 46(3):202-207. PubMed ID: 31395477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceptability of an "on-demand" pre-exposure HIV prophylaxis trial among men who have sex with men living in France.
    Lorente N; Fugon L; Carrieri MP; Andreo C; Le Gall JM; Cook E; Aboulker JP; Capitant C; Molina JM; Spire B
    AIDS Care; 2012; 24(4):468-77. PubMed ID: 22085083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Configuring the users of new HIV-prevention technologies: the case of HIV pre-exposure prophylaxis.
    Holt M
    Cult Health Sex; 2015; 17(4):428-39. PubMed ID: 25270549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Considerations for implementing oral preexposure prophylaxis: a literature review.
    Sowicz TJ; Teitelman AM; Coleman CL; Brawner BM
    J Assoc Nurses AIDS Care; 2014; 25(6):496-507. PubMed ID: 25305026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-exposure prophylaxis for HIV in Brazil: hopes and moral panic in the social construction of a biomedical technology.
    Brigeiro M; Monteiro S
    Cult Health Sex; 2023 Aug; 25(8):1055-1069. PubMed ID: 36153738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Resource Challenges to Integrating HIV Pre-Exposure Prophylaxis (PrEP) into the Public Health System in Kenya: A Qualitative Study.
    Mack N; Wong C; McKenna K; Lemons A; Odhiambo J; Agot K
    Afr J Reprod Health; 2015 Mar; 19(1):54-62. PubMed ID: 26103695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing HIV infection: pre-exposure and postexposure prophylaxis.
    Doblecki-Lewis S; Kolber MA
    IUBMB Life; 2014 Jul; 66(7):453-61. PubMed ID: 24975125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Provider Utilization of a Clinical Decision Support Alert and Association with HIV Pre-exposure Prophylaxis Prescription Rates.
    Chan CT; Vo M; Carlson J; Lee T; Chang M; Hart-Cooper G
    Appl Clin Inform; 2022 Jan; 13(1):30-36. PubMed ID: 35021253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Untangling the cost-effectiveness knot: who is oral antiretroviral HIV pre-exposure prophylaxis really for?
    Hankins CA
    Expert Rev Pharmacoecon Outcomes Res; 2014 Apr; 14(2):167-70. PubMed ID: 24552641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-exposure prophylaxis for South African adolescents: What evidence?
    Bekker LG; Gill K; Wallace M
    S Afr Med J; 2015 Nov; 105(11):907-11. PubMed ID: 26632316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GRINDR AND PrEP.
    Posit Aware; 2016; 28(1):31. PubMed ID: 27483970
    [No Abstract]   [Full Text] [Related]  

  • 39. Saying 'No' to PrEP research in Malawi: what constitutes 'failure' in offshored HIV prevention research?
    Peterson K; Folayan MO; Chigwedere E; Nthete E
    Anthropol Med; 2015 Dec; 22(3):278-94. PubMed ID: 26422196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community Federally Qualified Health Centers as Homes for HIV Preexposure Prophylaxis: Perspectives from South Florida.
    Doblecki-Lewis S; Jones D
    J Int Assoc Provid AIDS Care; 2016 Nov; 15(6):522-528. PubMed ID: 27502831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.